Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

“The real stroke of brilliance is the notion that you make the cell younger, and then it would be more resilient to injury,” ...

Parker Waichman LLP, a nationally recognized law firm dedicated to representing victims of defective drugs, is actively investigating claims involving vision loss, blindness, and non-arteritic ...

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

A US resident lost around 40 kilos using a weight-loss drug but developed vision problems, to be ultimately diagnosed with ...

My residency director, David Carey, used to say ironically, “If you step back and take a careful look, you’ll see there’s a ...

Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Neuro-ophthalmology focuses on diseases that affect the optic nerve and the visual pathways. Due to the complexity of the ...

Patients using popular weight loss medications, such as Ozempic and Wegovy, are being urged to undergo eye examinations due ...

Cigarette smoking significantly reduces choroidal vascularity, as indicated by a decreased choroidal vascularity index (CVI).

A major study has raised concerns that weight loss injections, like Ozempic, may increase the risk of an eye condition that ...